锥形束CT引导在线自适应放疗在乳腺及腋窝靶区中的临床实施
结果显示oART在所有乳腺靶区可行,治疗时间可接受,急性毒性主要为0-1级,患者满意度良好,剂量学满足临床标准。
要点
- oART在乳腺及腋窝靶区实施可行,中位治疗时间14.5-25.8分钟。
- 所有自适应计划均满足PTV D98%≥95%的覆盖标准。
- 急性毒性主要为0-1级,患者满意度良好。
核心结论
- oART在乳腺所有靶区实施可行,治疗时间可接受,急性毒性轻微,患者舒适度好,剂量学满足临床标准。
主要发现
- 中位治疗时间从右侧WBI的14.5分钟(范围10.1-29.2)到左侧WBI+腋窝I-II级的25.8分钟(范围22.6-36.8)。
- 所有自适应计划均满足靶区PTV D98%≥95%的覆盖标准。
- 与计划CT相比,自适应计划的乳腺CTV相对体积在分次1减少,在分次2-5增加。
- 毒性主要为0级和1级,患者满意度良好。
关键数值与推荐
- 靶区PTV覆盖标准为D98%≥95%。
- 放疗方案包括5×5.2 Gy和15×2.67 Gy。
临床怎么用
- oART可消除术后乳腺放疗中因每日轮廓和手臂位置变化导致的重摆位和离线重计划需求。
- 未来需关注oART在放疗推量适应症中的实施及获益人群选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Daily differences in breast contour and arm positioning can result in frequent re-positioning and offline re-planning in postoperative breast radiotherapy (RT). Online adaptive radiotherapy (oART) enables daily adaptation of the radiotherapy treatment plan. This study aimed to implement oART in breast and axillary target volumes to eliminate the need for repositioning and replanning. MATERIALS AND METHODS: Patients referred for postoperative partial breast irradiation (PBI) and whole breast irradiation (WBI)/post-mastectomy radiotherapy (PMRT) with or without axillary levels I-II (5x5.2 Gy) or I-IV (15x2.67 Gy) were included. On-couch treatment times were evaluated as well as dosimetry, target volume, acute toxicity, and in-house satisfaction questionnaires. RESULTS: Seventy-nine patients (n = 66 PBI/WBI/PMRT, n = 13 WBI + axillary levels I-II/I-IV) were treated with postoperative RT (465 fractions). On-couch median time ranged from 14.5 (range: 10.1-29.2) minutes for right-sided WBI to 25.8 (range: 22.6-36.8) minutes for left-sided WBI + axillary levels I-II. All adapted treatment plans met the D98% ≥ 95 % coverage criteria for the target PTV. Relative breast CTV volumes for the adapted plan decreased in fraction 1 and increased in fractions 2-5 compared to the CTV volume on the planning CT. Toxicity was mainly grades 0 and 1 and patient satisfaction was good. CONCLUSION: Implementation of oART was feasible in all breast target volumes with acceptable treatment duration, only mild acute toxicity, favorable patient-reported comfort, and dosimetry that met clinical standards. Future work will focus on the implementation of oART in RT boost indications, and selection of breast cancer patients who will benefit most from oART.
引用
- van Vlaenderen ARW, Middelburg-van Rijn JG, Nelissen KJ, et al. Cone beam computed tomography-guided online adaptive radiation therapy: Clinical implementation in breast and axillary target volumes. Clin Transl Radiat Oncol. 2025. PMID: 41403709. doi:10.1016/j.ctro.2025.101086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。